Crossmark

Clinical Characteristics of a Non-Alcoholic Fatty Liver Disease Population Across the Fibrosis Spectrum Measured by Magnetic Resonance Elastography: Analysis of Screening Data

Crossref DOI link: https://doi.org/10.1007/s12325-020-01503-x

Published Online: 2020-10-01

Published Print: 2020-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Andersen, Grit http://orcid.org/0000-0001-9260-7165
Plum-Mörschel, Leona

Hockings, Paul D.

Morsing, Anni

Palle, Mads S.

Svolgaard, Olivia

Flint, Anne
Clinical Trials ^BETA

Clinical trials referenced in this document:

nct03357380 at ClinicalTrials.gov

Documents that mention this clinical trial

Clinical Characteristics of a Non-Alcoholic Fatty Liver Disease Population Across the Fibrosis Spectrum Measured by Magnetic Resonance Elastography: Analysis of Screening Data
https://doi.org/10.1007/s12325-020-01503-x
Funding

Funding for this research was provided by:

Novo Nordisk A/S, Denmark
License Information

Text and Data Mining valid from 2020-10-01

Version of Record valid from 2020-10-01
More Information

Article History

Received: 29 July 2020

Accepted: 11 September 2020

First Online: 1 October 2020

Document is current

Any future updates will be listed below